/Companies

Known Medicine

AcquiredYC S20

Salt Lake City, US · Founded 2020 · 17 employees · 12 known investors

Find your way into Known Medicine

Sign up to see every warm intro you have to Known Medicine

  • Paths you didn't know you had: your email and LinkedIn already hold routes to the Known Medicine team. We find them for you
  • 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
  • Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone

Days of research, done the moment you sign in, with every route ranked by how warm it is.

Known Medicine develops a predictive engine using AI and patient datasets to identify optimal cancer treatments for individual patients. The company serves oncologists and cancer patients through computational analysis of biomaterials and drug-discovery data.

Founders & leadership· Y Combinator alumni (S20)

Known Medicine was founded in 2020 by Andrea Mazzocchi and Katie-Rose Skelly.

AMAndrea Mazzocchi
Andrea MazzocchiCo-founder, PhD2020–2023Andrea Mazzocchi co-founded and led Known Medicine, an AI-driven oncology drug development company acquired by Pathos AI in 2023, and previously worked as a consultant with early-stage companies; he is now CEO of Play Health, which applies AI and data analytics to women's health in perimenopause and menopause.
KSKatie-Rose Skelly
Katie-Rose SkellyCo-founder, MSuntil 2023Katie-Rose Skelly is co-founder of Known Medicine, which develops AI-powered computational tools to identify personalized cancer treatments for individual patients. Her work focuses on building datasets and translating AI insights into clinical applications.30 Under 30 2023
IMIan Miller
Ian MillerSenior Automation Engineer2022–2023CTO & Co-Founder at Play Health

Investors · 12

Caffeinated CapitalreportedSan Francisco · $3M – $50M

How we know: funding news · medicalfinancenews.com · Y Combinator's founder network · Not right? Tell us

FORWARD.onereportedAmstelveen · $1M – $3M

How we know: Y Combinator's founder network · Not right? Tell us

Khosla VenturesreportedMenlo Park · $100K – $20M

How we know: funding news · medicalfinancenews.com · Y Combinator's founder network · Not right? Tell us

OATVreportedSan Francisco

How we know: medicalfinancenews.com · Y Combinator's founder network · Not right? Tell us

SP Investment Fundreported

How we know: Y Combinator's founder network · Not right? Tell us

SymBiosisreportedBentonville

How we know: Y Combinator's founder network · Not right? Tell us

Also in the syndicate · 1

Forward VC

Funding

SEC filings, press & company announcements

$7.2M disclosed across 1 round · 2021

Source: company announcements and press reports — follow each round's link for the claim.

Founder mafia

3 people who came through Known Medicine went on to found or lead other companies.

Related companies · 7

Numerion LabsNumerion combines drug discovery expertise with machine learning and computational chemistry. The company applies AI to drug development.
Notable LabsNotable Labs operates an automated laboratory that tests combinations of existing drugs against individual patients' blood cancer cells to identify effective treatment options for patients whose cancers have become resistant to standard therapies.
Cambridge Cancer GenomicsCCG.ai develops software that uses clinical and genomic data to help oncologists select appropriate cancer treatments for individual patients, with a focus on identifying predictive biomarkers linked to treatment response.
FidoCureOne Health operates a clinical trial platform using canine cancer data to accelerate and de-risk human oncology drug development. The company leverages a dataset of 2 billion datapoints from dogs with naturally occurring cancer to serve as a comparative model for pharmaceutical R&D, helping drug developers validate efficacy and identify biomarkers before human trials.
Foundation MedicineFoundation Medicine is a precision medicine company that develops comprehensive genomic profiling and companion diagnostic tests for cancer and other diseases. It serves patients, healthcare providers, and biopharma companies, with tests available across all U.S. states and 45+ countries.
Clear GeneClear Gene develops RNA diagnostics for detecting residual solid tumors in cancer patients and provides software and reagent kits to help clinical laboratories process COVID-19 samples more efficiently using existing equipment.
BioworldBioWorld is a suite of daily news and data services covering therapeutics, medical technology, biopharma business transactions, and drug R&D, serving biopharmaceutical and medtech industry professionals. Owned by Clarivate, it publishes products including BioWorld, BioWorld Science, and BioWorld Asia with reporting from writers stationed globally.

Companies working in the same space as Known Medicine.

Legal entities · 1

corporate structure
Known Medicine Inc.

Frequently asked questions

What does Known Medicine do?
Known Medicine develops a predictive engine using AI and patient datasets to identify optimal cancer treatments for individual patients. The company serves oncologists and cancer patients through computational analysis of biomaterials and drug-discovery data.
Who founded Known Medicine?
Known Medicine was founded by Andrea Mazzocchi, Katie-Rose Skelly in 2020.
Who are Known Medicine's investors?
Known Medicine's investors include Y Combinator, Cota Capital, Forward Venture Capital, StartX, Caffeinated Capital, FORWARD.one, Khosla Ventures, Kickstart and 3 more.
How much funding has Known Medicine raised?
Known Medicine has disclosed $7.2M raised across 1 round.
Where is Known Medicine headquartered?
Known Medicine is headquartered in Salt Lake City, US.